Ask AI
ProCE Banner Series

Individualizing ART Management in 2023 and Beyond

Join us in this live virtual symposium, where a panel of expert faculty from around the globe discusses the latest strategies for individualizing ART through a review of case studies, with attention to concerns in specific populations (eg, women and racial and ethnic minority patients) and provides perspectives on how future ART regimens may offer additional options.

  AMA
Credits Available

1.5

Who Should Attend

This program is intended for physicians and other healthcare professionals who provide care for people with HIV infection.

All Events

Individualizing ART Management in 2023 and Beyond

Past Events

September

14

2023

3:00 PM - 4:30 PM Eastern Time (ET)

Virtual

Topics

  • Introduction
  • Case studies of major factors driving ART individualization in 2023
    • Panel discussion representing global expert perspectives, including:
        • ART initiation and switch strategies
        • Management of comorbidities, drug–drug interactions, and polypharmacy
        • Application of the latest data on ART-related weight gain
  • New directions in individualizing ART
  • Question and answer session

CME/CE Info

Goal Statement
The goal of this activity is to improve healthcare professionals’ competence in devising individualized ART strategies for each person with HIV and identifying potential solutions to their unmet needs.

 

Target Audience
This program is intended for physicians and other healthcare professionals who provide care for people with HIV infection.

 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply available evidence when selecting an individualized regimen for each person with HIV when initiating ART
  • Identify an appropriately individualized switch regimen for each person with HIV when modifying therapy in virologically suppressed individuals
  • Identify how the next wave of ART agents may enhance patient satisfaction and treatment outcomes by providing additional options for individualized therapy

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

Acknowledgement

Provided by Clinical Care Options, LLC

This activity is supported through an Independent Medical Education grant from Merck Sharp & Dohme LLC, Rahway, NJ, USA.